(MENAFN- America News Hour)
Kenneth Research recently added a report on Autoimmune Diseases Treatment Industry Market in its database of market research reports which provides its readers an in-depth analysis on the latest trends, growth opportunities and growth drivers that are associated with the growth of the market. The report additionally shares critical insights on the COVID-19 impacts on the Autoimmune Diseases Treatment Industry Market, along with the compound growth rate (CAGR) of the market for a projected period between 2022 and 2031. The report also includes analysis of the market by utilizing different analytical tools, such as PESTEL analysis and Porter's five forces analysis. These tools also provide an in-depth analysis on the micro and macro-environmental factors that are associated with the growth of the market during the forecast period.
U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Autoimmune Diseases Treatment Industry Market products.
Request of this Sample Report –
“The global autoimmune disease market is estimated to be ~USD 4.9 billion by the end of 2021 and is likely to foster at a CAGR of ~10% over the period 2022-2030. Autoimmune diseases are diseases that occur due to damage to healthy body tissues caused by an individual's own immune system. Immune system diseases can cause the immune system to be overactive or underactive. Most autoimmune diseases are chronic and cannot be cured. Bacteria, viruses, toxins, and blood and tissues outside the body produce antigens that can cause autoimmune diseases. The antibodies produced by the immune system protect the body from the destruction of these antigens, which affect many parts or tissues of the body. Autoimmune diseases cause abnormal growth of organs, destruction of body tissues, and changes in organ function. The areas commonly affected by autoimmune diseases are blood vessels, connective tissue, joints, muscles, and red blood cells (RBC). Addison's disease, celiac disease, dermatomyositis, rheumatoid arthritis, thyroid disease, type 1 diabetes and multiple sclerosis are some common autoimmune diseases. A person may have multiple autoimmune diseases at the same time. Compared with men, women have a higher prevalence of autoimmune diseases.
Symptoms associated with autoimmune diseases include inflammation, fatigue, fever, joint pain, and skin rash. Inflammation can cause redness, heat, pain, and swelling of the affected body parts. Diagnostic tests for autoimmune diseases include autoantibody test, antinuclear antibody test, urinalysis, complete metabolism test, and erythrocyte sedimentation rate (ESR). The treatment of autoimmune diseases depends on the type of disease. The treatment of autoimmune diseases includes blood transfusions, supplements, medications, and physical therapy. Some drugs used to treat autoimmune diseases include NSAID, DMARD, biological DMARD, and 5-ASA. Therapies such as bridging therapy, topical therapy, light therapy, and recombinant technology are also used to treat these diseases.
In addition, certain lifestyle changes, such as healthy diet and physical exercise, and treatment of autoimmune diseases, can help control autoimmune diseases. At present, North America dominates the global autoimmune disease treatment market, followed by Europe. This is due to the prevalence of autoimmune diseases and the increase in investment in research and development of new drugs in these areas. Asia is expected to become the fastest growing market in the next five years. This is due to the increasing ageing of the population and the improvement of sanitation infrastructure in the region. In addition, the increasing awareness of better healthcare facilities has also promoted the growth of the autoimmune disease treatment market in the region.
Increased awareness of healthcare and increased R&D investment in the pharmaceutical and life science fields are some of the key factors driving the growth of the global autoimmune disease treatment market. In addition, more and more government initiatives to control autoimmune diseases have also promoted the growth of the autoimmune disease market. However, the lack of standard treatments for autoimmune diseases and low health insurance coverage for these diseases hinder the growth of this market. The increased availability and affordable treatments of biosimilars can open up opportunities for new players in the global autoimmune disease treatment market. In addition, the safety and quality of autoimmune disease control therapies may pose a challenge to the growth of the global autoimmune disease treatment market. The main companies operating in this market are Abbott Laboratories, Active Biotech, Eli Lilly, AstraZeneca, Lupin Co., Ltd., 4SC AG, Amgen, Bristol-Myers Squibb, AutoImmune Inc., Pfizer, Gülen Susik Company, F. Hoffmann -La Roche Ltd. and Johnson & Johnson Ltd.
THE MAIN FEATURES OF THIS REPORT: The driving factors, constraints and challenges that shape the market dynamics of autoimmune disease treatment The latest innovations and key industry events The business strategy analysis of top players, market estimation and forecasting of autoimmune disease treatment (2022-2030).”
Access Full Report Here –
About Us
Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defense, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.
Contact Us
Name: Kenneth research
Email:
Phone: +1 313 462 0609
Mason Mount
Mason Mount is is an energetic and versatile freelance writer for 5 years, he pens down any type of article and web content. He is a Cambridge University Business English Certificate (Europe Level) holder. He is analytical, enthusiastic, and ingenious, with the essence to work variously, strives to emerge as a lucrative individual who has a grasp on market. Congenial Interpersonal skills and the competence to grab every single trivia with foolproof analysis is something he primarily posses.
MENAFN05072022004545010068ID1104478908
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.